[Practice guideline for patients with osteoporosis].


Journal

Zhonghua nei ke za zhi
ISSN: 0578-1426
Titre abrégé: Zhonghua Nei Ke Za Zhi
Pays: China
ID NLM: 16210490R

Informations de publication

Date de publication:
01 Dec 2020
Historique:
entrez: 1 12 2020
pubmed: 2 12 2020
medline: 27 1 2021
Statut: ppublish

Résumé

In recent years, osteoporosis (OP) has become one of the main diseases affecting the health of middle-aged and elderly people in China, and the prevalence of OP has increased significantly. The clinical diagnosis and treatment guidelines for this disease are also constantly updated. The overall principles speciallyemphasise that doctors and patients need to work together to negotiate the details of the diagnosis and treatment guidelines, in order to improve the OP clinical diagnosis and treatment rate. Therefore, patients' knowledge of the disease, understanding of clinical guidelines, and cooperation with doctors to implement diagnosis and treatment plans are very important. In this study, from the most concerned issues of the patients, we established the OP patient practice guideline working group. 14 recommendations, as the OP patient practice guidelines, are proposed in accordance with the relevant principles of the "World Health Organization guidelines development manual" and the international normative process. 骨质疏松症(OP)的患病率明显上升,已成为我国中老年人群的重要健康问题,提高OP临床诊治达标率需医患携手共同协商诊疗过程中的细节。因此,患者对疾病的认识、对诊治指南的理解以及配合医生执行诊疗方案是非常重要的环节。本指南从患者关切的问题出发,采用《世界卫生组织指南制订手册》的规范流程和相关原则,组成OP患者实践指南工作组,提出OP患者实践指南推荐意见14条。.

Autres résumés

Type: Publisher (chi)
骨质疏松症(OP)的患病率明显上升,已成为我国中老年人群的重要健康问题,提高OP临床诊治达标率需医患携手共同协商诊疗过程中的细节。因此,患者对疾病的认识、对诊治指南的理解以及配合医生执行诊疗方案是非常重要的环节。本指南从患者关切的问题出发,采用《世界卫生组织指南制订手册》的规范流程和相关原则,组成OP患者实践指南工作组,提出OP患者实践指南推荐意见14条。.

Identifiants

pubmed: 33256336
doi: 10.3760/cma.j.cn112138-20200904-00792
doi:

Types de publication

Journal Article

Langues

chi

Sous-ensembles de citation

IM

Pagination

953-959

Auteurs

M L Qiu (ML)

Guangdong Provincial Clinical Research Center for Immunological Diseases, Guangzhou 510630, China.

Y Xie (Y)

Guangdong Provincial Clinical Research Center for Immunological Diseases, Guangzhou 510630, China.

X H Wang (XH)

Department of Radiology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.

X Q Wang (XQ)

WHO Collaborating Centre for Guideline Implementation and Knowledge Translation/Evidence Based Medicine Center, Lanzhou University, Lanzhou 730000, China.

D B Zhao (DB)

Department of Rheumatology and Immunology, First Affiliated Hospital of the Second Military Medical University(Changhai Hospital), Shanghai 200433, China.

H Q Zhou (HQ)

Department of Rheumatology and Immunology, Fourth Medical Center of People's Liberation Army General Hospital, Beijing 100048, China.

Y Q Zhou (YQ)

Medical Ethics Committee, Clinical Research Center, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.

L Yan (L)

Department of Endocrinology, Second Affiliated Hospital of Sun Yat-sen University, Guangzhou 510030, China.

B L Liang (BL)

Department of Radiology, Second Affiliated Hospital of Sun Yat-sen University, Guangzhou 510030, China.

H L Shen (HL)

Osteoporosis Patient Organization of Guangzhou Pukang Charity Foundation, Guangzhou 510630, China.

S Y Cao (SY)

Guangdong Provincial Clinical Research Center for Immunological Diseases, Guangzhou 510630, China.

Y Ding (Y)

Department of Orthopedics, Second Affiliated Hospital of Sun Yat-sen University, Guangzhou 510030, China.

J R Gu (JR)

Guangdong Provincial Clinical Research Center for Immunological Diseases, Guangzhou 510630, China; Department of Rhenmatology and Immunology, Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen 518107, China.

X F Zeng (XF)

Department of Rheumatology and Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.

K H Yang (KH)

WHO Collaborating Centre for Guideline Implementation and Knowledge Translation/Evidence Based Medicine Center, Lanzhou University, Lanzhou 730000, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH